The nation's top infectious disease expert expects COVID-19 vaccination to be made available for children aged 5 to 11 years by early November; Walmart recalls aromatherapy spray due to rare and deadly bacteria contamination; COVID-19–related brain fog has been found to persist in patients for months after infection.
As reported by Reuters, children aged 5 to 11 years will likely be able to be vaccinated against COVID-19 starting in early November. The chief medical advisor to President Joe Biden, Anthony Fauci, MD, said yesterday that he predicts the regulatory approval and recommendation from the CDC to be issued by the first or second week of November. Currently, FDA officials are reviewing the Pfizer/BioNTech application of its 2-dose vaccine in younger children, with a panel of outside advisers scheduled to meet on October 26. The CDC will meet to discuss their recommendations on November 2 and 3.
Approximately 3900 bottles of an essential-oil aromatherapy spray from Walmart are being recalled due to potential contamination with a rare and deadly bacteria, Burkholderia pseudomallei. Reported by NPR, Walmart's Better Homes & Gardens–branded Essential Oil Infused Aromatherapy Room Spray with Gemstones has been associated with 4 confirmed cases, with 2 cases being fatal. The bacteria is known to cause meliodosis, a difficult-to-diagnose and deadly condition that typically develops in tropical climates, especially Southeast Asia and northern Australia.
Reported by CNN, cognitive impairment from COVID-19, also known as brain fog, was found in a recent study o persist for months after infection, even in those without cases of severe disease or hospitalization, according to JAMA Network Open. In the study, findings indicated that nearly 1 in 4 patients with COVID-19 from the Mount Sinai Health System registry experienced a cognitive-related issue, with hospitalized individuals shown to be more likely to have brain fog after infection. Overall, 23% of patients reported issues with memory recall, 18% showed deficits in their cognitive processing speed, and 15% had deficits in phonemic fluency in their speaking.
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More